Temozolomide chemotherapy combined with radiotherapy versus radiotherapy alone after surgery in patients with high-risk low-grade gliomas.

医学 替莫唑胺 放射治疗 化疗 单变量分析 外科 无进展生存期 内科学 多元分析 肿瘤科
作者
Yilin Hou,Huan Yu,Yufu Zhang,Lei Zhu,Yuqian Li
出处
期刊:Journal of B.U.ON. : official journal of the Balkan Union of Oncology 卷期号:26 (3): 977-983 被引量:1
标识
摘要

PURPOSE The purpose of this study was to compare the clinical efficacy and safety of temozolomide (TMZ) combined with three-dimensional conformal radiotherapy (3D-CRT) and radiotherapy alone after surgery in patients with high-risk low-grade gliomas (LGGs). METHODS Patients (N=110) with LGGs were enrolled. Patients receiving TMZ chemotherapy combined with radiotherapy were considered as combination group (n=55), while those treated with radiotherapy alone were regarded as control group (n=55). The patients were followed up, and the overall survival (OS) and progression-free survival (PFS) were recorded. Finally, factors possibly affecting prognosis were analyzed. RESULTS The follow-up results exhibited median OS [(67.4±8.8) months vs. (63.9±8.6) months] and median PFS [(51.1±7.6) months vs. (46.8±6.9) months] as well as three-year OS rate and three-year PFS rate in combination group and control group. Log-rank test indicated that the difference in OS was not statistically significant between the two groups of patients, and PFS in combination group was significantly superior to that in control group. The results of univariate and multivariate analysis displayed that age <40 years old and complete tumor resection were independent factors affecting the three-year OS of patients with high-risk LGGs. Besides, age <40 years old, complete tumor resection and TMZ chemotherapy combined with radiotherapy after surgery were independent factors affecting the three-year PFS of patients with high-risk LGGs. CONCLUSION TMZ chemotherapy combined with radiotherapy after surgery in patients with high-risk LGGs can prominently improve clinical efficacy, prolong PFS, and facilitate tolerance to adverse reactions, but not prolong the OS of patients. The OS is notably prolonged in patients aged <40 years old and receiving complete tumor resection.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
ZD完成签到 ,获得积分10
4秒前
6秒前
英姑应助普鲁卡因采纳,获得10
9秒前
冰糕发布了新的文献求助10
11秒前
BettyNie完成签到 ,获得积分10
13秒前
优雅的平安完成签到 ,获得积分10
13秒前
冰糕完成签到,获得积分10
18秒前
20秒前
852应助完犊子采纳,获得10
24秒前
ruochenzu发布了新的文献求助10
25秒前
不想洗碗完成签到 ,获得积分10
27秒前
const完成签到,获得积分10
31秒前
hjx完成签到 ,获得积分10
31秒前
稳重的尔安完成签到,获得积分10
33秒前
量子星尘发布了新的文献求助10
34秒前
缓慢的饼干完成签到 ,获得积分10
34秒前
saturn完成签到 ,获得积分10
34秒前
金桔希子完成签到,获得积分10
35秒前
Breeze完成签到 ,获得积分10
35秒前
35秒前
昏睡的眼神完成签到 ,获得积分10
36秒前
文心同学完成签到,获得积分0
37秒前
demom完成签到 ,获得积分10
39秒前
duckspy完成签到 ,获得积分10
39秒前
完犊子发布了新的文献求助10
41秒前
普鲁卡因发布了新的文献求助30
42秒前
chenkj完成签到,获得积分10
44秒前
EricSai完成签到,获得积分10
44秒前
ikun完成签到,获得积分10
44秒前
李李发布了新的文献求助10
44秒前
章鱼小丸子完成签到 ,获得积分10
44秒前
byby完成签到,获得积分10
46秒前
THEO完成签到 ,获得积分10
47秒前
李健的小迷弟应助完犊子采纳,获得10
48秒前
49秒前
乐观的问兰完成签到 ,获得积分10
50秒前
书生完成签到,获得积分10
50秒前
朱佳宁完成签到 ,获得积分10
51秒前
Master完成签到 ,获得积分10
52秒前
怕孤独的香菇完成签到 ,获得积分10
52秒前
高分求助中
【提示信息,请勿应助】关于scihub 10000
Les Mantodea de Guyane: Insecta, Polyneoptera [The Mantids of French Guiana] 3000
徐淮辽南地区新元古代叠层石及生物地层 3000
The Mother of All Tableaux: Order, Equivalence, and Geometry in the Large-scale Structure of Optimality Theory 3000
Handbook of Industrial Diamonds.Vol2 1100
Global Eyelash Assessment scale (GEA) 1000
Picture Books with Same-sex Parented Families: Unintentional Censorship 550
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 4038112
求助须知:如何正确求助?哪些是违规求助? 3575788
关于积分的说明 11373801
捐赠科研通 3305604
什么是DOI,文献DOI怎么找? 1819255
邀请新用户注册赠送积分活动 892655
科研通“疑难数据库(出版商)”最低求助积分说明 815022